doctor

Do Physicians and Researchers Profit and Trade Stock on Privileged Information

by

An interesting article titled “Do Physicians/Researchers Trade Stock Based on Privileged Information?” written by Elie Donath and Mark J. Eisenberg appears in the Summer 2012 issue of The Journal of Law, Medicine & Ethics (vol. 40, issue 2, pages 391-393). Speculation is made that “…physicians/researchers are inappropriately profiting (by buying or selling stock) from information derived from advance copies of high-impact clinical trial data distributed by medical conferences or journals.” A case study is made looking at the American Society of Clinical Oncology. Up until 2008 ASCO selectively and discreetly distributed abstracts from all forthcoming presentations at the ASCO Conference to ASCO members 2 weeks prior to them becoming publicly accessible at the conference. The authors used multiple linear regression to look at the percentage change in stock price on the first trading day following the release of these abstracts. A … Read more

Politics of Dental Anesthesiology

by

A recent article titled “Dental anesthesiology falls short of becoming ADA specialty,” by Rob Goskowski, Nov. 1, 2012, located at http://www.drbicuspid.com/index.aspx?sec=sup&sub=rst&pag=dis&ItemID=311903, discusses a recent vote that took place at the House of Delegates during the 2012 American Dental Association (ADA) Annual Session. The House of Delegates voted against recognizing Dental anesthesiology as the 10th ADA recognized specialty. Steven Ganzberg, a clinical professor and the chair of dental anesthesiology at UCLA says: “This action by the ADA confirms that the ADA process of specialty approval is fatally flawed….This was clearly an effort by the ADA, through AAOMS [the American Association of Oral and Maxillofacial Surgeons], to restrict professional activities that specialty recognition would have provided.” Dr. Ganzberg and some other supporters were hoping that the specialty would be approved as they felt it would lead to increased training and emergency preparedness … Read more

Litigation In the National Health Service for Oral and Maxillofacial Surgery

by

An article appears in the British Journal of Oral and Maxillofacial Surgery titled “Litigation in National Health Service oral and maxillofacial surgery: review of the last 15 years,” by A. Gulati et. al. (50, pages 385-388, 2012). The authors state: “Published data regarding litigation in other surgical specialties are plentiful, but to our knowledge there is little detailed analysis of claims within the specialty of oral and maxillofacial surgery (OMFS) despite information being freely available from the NHS Litigation Authority (NHSLA) under the Freedom of Information Act.” The authors used data from April 1995 to August 2010 from the NHSLA. A total of 318 claims were registered during this 15 years. Claims have been increasing in recent years. Of these claims 253 were closed. A total of 137 claims (54%) resulted in compensation with the rest not being successful. The … Read more

The Right to Health and Information

by

An interesting article is written by Trudo Lemmens and Candice Telfer titled “Access to Information and the Right to Health: The Human Rights Case for Clinical Trials Transparency,” which appeared in the 2011 issue of the American Journal of Law and Medicine (vol. 38, pages 63-112). In the article the authors argue that information about clinical trials should be recognized as a fundamental component of the right to health. The authors make a mention of two controversies in recent years. The first is of GlaxoSmithKline and its use of the antidepressant Paxil for treatment of depression in the pediatric population. In 2004, the Attorney General of New York prosecuted GSK for allegedly hiding negative data, selective publishing of positive data, and use of skewed publications to promote off-label prescriptions. The second case is the mention of Vioxx in which the … Read more